Oxidized LDL is stable in human serum under extended thawed-state conditions ranging from -20 °C to room temperature
- PMID: 36578466
- PMCID: PMC9791165
- DOI: 10.1016/j.jmsacl.2022.12.001
Oxidized LDL is stable in human serum under extended thawed-state conditions ranging from -20 °C to room temperature
Abstract
Introduction: Oxidized LDL (oxLDL) is formed by the spontaneous reaction between aldehyde byproducts of lipid peroxidation and lysine residues of apolipoprotein B within LDL. Clinically, oxLDL is used as a marker of coronary artery disease and predictor of metabolic syndrome risk. Despite its popularity as a clinical marker, no systematic studies of oxLDL stability, in which serum or plasma has been pre-analytically exposed to an array of different time and temperature conditions, have been carried out.
Objective: To systematically evaluate the stability of oxLDL in human serum samples exposed to thawed conditions (> -30 °C) for varying periods of time while monitoring a second protein/small molecule redox system as a positive control for non-enzymatic biomolecular activity.
Methods: OxLDL was measured in serum samples, from 24 different humans, that had been pre-exposed to three different time courses at 23 °C, 4 °C and -20 °C using ELISA kits from Mercodia that employ the 4E6 mouse monoclonal antibody. A liquid chromatography/mass spectrometry-based marker of serum exposure to thawed conditions known as ΔS-Cys-Albumin was employed as a positive control.
Results: OxLDL was stable in serum exposed to 23 °C for up to 48 h, 4 °C for 21 days, or -20 °C for 65 days. ΔS-Cys-Albumin changed dramatically during these time courses (p < 0.001).
Conclusions: OxLDL is remarkably stable ex vivo in human serum samples exposed to thawed conditions.
Keywords: CAD, coronary artery disease; CHD, coronary heart disease; OxLDL, oxidized low-density lipoprotein; Oxidized LDL; Serum; Stability.
© 2022 THE AUTHORS.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures


Similar articles
-
Tracking the Stability of Clinically Relevant Blood Plasma Proteins with Delta-S-Cys-Albumin-A Dilute-and-Shoot LC/MS-Based Marker of Specimen Exposure to Thawed Conditions.Mol Cell Proteomics. 2022 Nov;21(11):100420. doi: 10.1016/j.mcpro.2022.100420. Epub 2022 Sep 28. Mol Cell Proteomics. 2022. PMID: 36182099 Free PMC article.
-
Is plasma oxidized low-density lipoprotein, measured with the widely used antibody 4E6, an independent predictor of coronary heart disease among U.S. men and women?J Am Coll Cardiol. 2006 Sep 5;48(5):973-9. doi: 10.1016/j.jacc.2006.03.057. Epub 2006 Aug 17. J Am Coll Cardiol. 2006. PMID: 16949489
-
Biochemically Tracked Variability of Blood Plasma Thawed-State Exposure Times in a Multisite Collection Study.Biopreserv Biobank. 2020 Oct;18(5):376-388. doi: 10.1089/bio.2019.0137. Epub 2020 Jun 30. Biopreserv Biobank. 2020. PMID: 32608993 Free PMC article.
-
Oxidized low-density lipoprotein as a biomarker of cardiovascular diseases.Crit Rev Clin Lab Sci. 2015;52(2):70-85. doi: 10.3109/10408363.2014.992063. Epub 2014 Dec 24. Crit Rev Clin Lab Sci. 2015. PMID: 25537066 Review.
-
[Atherosclerosis and sensitive determination of oxidized LDL using monoclonal antibody].Yakugaku Zasshi. 2002 Oct;122(10):745-53. doi: 10.1248/yakushi.122.745. Yakugaku Zasshi. 2002. PMID: 12400156 Review. Japanese.
Cited by
-
Delta-S-Cys-Albumin as a Marker of Pediatric Biospecimen Integrity.Biopreserv Biobank. 2024 Dec;22(6):578-585. doi: 10.1089/bio.2023.0121. Epub 2024 Apr 23. Biopreserv Biobank. 2024. PMID: 38651617
References
-
- Holvoet P., Collen D. Oxidized lipoproteins in atherosclerosis and thrombosis. FASEB J. 1994;8(15):1279–1284. - PubMed
-
- Holvoet P., Donck J., Landeloos M., Brouwers E., Luijtens K., Arnout J., Lesaffre E., Vanrenterghem Y., Collen D. Correlation between oxidized low density lipoproteins and von Willebrand factor in chronic renal failure. Thromb. Haemost. 1996;76(5):663–669. - PubMed
-
- Holvoet P., Macy E., Landeloos M., Jones D., Jenny N.S., Van de Werf F., Tracy R.P. Analytical performance and diagnostic accuracy of immunometric assays for the measurement of circulating oxidized LDL. Clin. Chem. 2006;52(4):760–764. - PubMed
-
- Yla-Herttuala S., Rosenfeld M.E., Parthasarathy S., Sigal E., Sarkioja T., Witztum J.L., Steinberg D. Gene expression in macrophage-rich human atherosclerotic lesions. 15-lipoxygenase and acetyl low density lipoprotein receptor messenger RNA colocalize with oxidation specific lipid-protein adducts. J. Clin. Invest. 1991;87(4):1146–1152. - PMC - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous